Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Yongzheng Pharmaceutical is a comprehensive pharmaceutical enterprise based in Guangzhou, China, dedicated to the R&D, manufacturing, and marketing of diverse medicinal products. The company maintains a strong presence in the pediatric, respiratory, and anti-infective therapeutic areas, producing both chemical drugs and traditional Chinese medicine (TCM) preparations. Its product portfolio includes widely used antibiotics such as amoxicillin and clavulanate potassium, as well as specialized pediatric formulations for cough and asthma. Operating from GMP-certified facilities, the company emphasizes quality control and technological innovation to support its domestic market expansion. Yongzheng Pharmaceutical is recognized for its integrated approach to healthcare, combining modern pharmaceutical science with traditional therapeutic practices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Yongzheng Pharmaceutical.